Last reviewed · How we verify

NCT04101266: PMSS

Pain Management in Arthtroscopic Shoulder Surgery

Completed NA Last updated 10 June 2021
What this trial tests

NA trial testing Interscalene block in Arthroscopic Shoulder Surgery in 76 participants. Completed in 1 April 2020.

Timeline
30 September 2019
Primary endpoint
1 March 2020
1 April 2020

Quick facts

Lead sponsorDiskapi Yildirim Beyazit Education and Research Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposetreatment
Enrollment76
Start date30 September 2019
Primary completion1 March 2020
Estimated completion1 April 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Diskapi Yildirim Beyazit Education and Research Hospital

Who can join

Adults 18 to 70, any sex, with Arthroscopic Shoulder Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It is compared that combined suprascapular and infraclavicular nerve blocks to interscalene nerve block for clinical outcomes after shoulder surgery

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Interscalene block

Trials testing the same drug.

Other recruiting trials for Arthroscopic Shoulder Surgery

Currently open trials in the same condition.

Other Diskapi Yildirim Beyazit Education and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04101266.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing